A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
PHASE1
The main objective of this study is to assess safety, tolerability, and pha...
Status
Completed
Location
The University of Chicago Medical Center /ID# 217196
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
PHASE1
The primary purpose of this Phase 1, open-label study is to evaluate the sa...
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
PHASE1
A study evaluating the safety, pharmacokinetics (PK), pharmacodynamics, and...